Related Experiment Video

Updated: May 11, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

The dark face of AMPK as an essential tumor promoter

Sang-Min Jeon1, Nissim Hay

  • 1Research Oncology; Genentech, Inc.; South San Francisco, CA USA.

Cellular Logistics
|May 17, 2013
PubMed

Insights

AMPK activation maintains cellular NADPH levels, promoting tumor cell survival and growth. This metabolic adaptation helps cancer cells cope with stress, offering new therapeutic targets.

Area of Science:

  • Cellular metabolism
  • Cancer biology
  • Biochemistry

Background:

  • AMPK's dual role in tumor growth is debated.
  • Physiological AMPK activation is linked to tumor growth and migration, potentially via ATP levels.

Purpose of the Study:

  • To investigate the predominant mechanism of AMPK in promoting tumor cell survival and solid tumor formation.
  • To elucidate the role of AMPK in maintaining cellular NADPH homeostasis under metabolic stress.

Main Methods:

  • Investigated AMPK's role in regulating intracellular NADPH levels.
  • Examined the impact of AMPK activation on fatty acid oxidation (FAO) and fatty acid synthesis (FAS).
  • Assessed the effect of AMPK on reactive oxygen species (ROS) levels and metabolic adaptation.

Main Results:

  • AMPK activation maintains intracellular NADPH levels, crucial for tumor cell survival.
  • AMPK promotes NADPH maintenance by activating FAO during glucose deprivation and inhibiting FAS during matrix detachment.
  • AMPK activation inhibits ROS production and facilitates metabolic adaptation to stress.

Conclusions:

  • Maintenance of cellular NADPH homeostasis is the primary mechanism by which AMPK promotes tumor cell survival and solid tumor formation.
  • Targeting cancer cell metabolic adaptation, influenced by AMPK, presents a therapeutic opportunity.
  • Combination therapies involving AMPK modulators and conventional anti-cancer drugs warrant further investigation.
Keywords:
ACCAMPKCaMKK2LKB1NADPHROScancerfatty acidsmetabolic stress

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...